General Medicine: The Michigan Cushing's Project

  • Print
  • Email
  • Favorite
  • Share
  • Newsletters

There have been advancements in the diagnosis and treatment of Cushing’s disease; however, previously there were no studies comparing the two most used medications—pergolide, a dopaminergic agonist, and cyproheptadine, a serotonin antagonist. Harold Schott II, DVM, PhD, presented “The Michigan Cushing’s Project” during the General Medicine session on Sunday afternoon. <

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners